Analysts’ Viewpoint on Market Scenario
Birth spacing methods amid the ongoing COVID-19 pandemic include precise advice on lactation amenorrhoea method (LAM) to enhance its efficacy, barrier methods such as condoms, and plentiful supplies of oral progestin-only pill, among others. The global contraceptives market is highly fragmented, with the presence of a large number of international as well as regional players. Since there is a lack of awareness about the advantages of contraceptives in developing economies, market stakeholders should initiate collaborative agreements with governments to educate women as well as related individuals about different alternatives. Manufacturers should increase the production of affordable contraceptive options to boost their uptake in developing economies.
A number of international and national organizations have initiated STI (sexually transmitted infections) awareness campaigns. Additionally, regulatory agencies in the U.K., such as the Medicines and Healthcare Regulatory Agency (MHRA), have approved injectable contraceptives. These approvals for women and men are expected to boost the growth of the global contraceptive market, particularly in developed countries.
The increase in the adoption of innovative contraceptive technologies in emerging countries is another factor propelling the global contraceptive market. People across the world have become more aware of the need for family planning.
Request a sample to get extensive insights into the Contraceptives Market
The COVID-19 pandemic has heightened the importance of family planning since most people have been spending time indoors. Manufacturers in the global market for contraceptives are capitalizing on this opportunity to ensure an uninterrupted supply of oral contraceptives, contraceptive injectables, and contraceptive devices. Healthcare organizations are stressing on the advantages of birth spacing during the ongoing pandemic, since avoiding pregnancy during such uncertain times is wise for women not only on a personal level but also from a public health perspective in terms of not adding to overburdened healthcare systems. Manufacturers are increasing efforts to prevent stock-outs for implants, oral contraceptive pills, and copper intrauterine devices.
To understand how our report can bring a difference to your business strategy, Ask for a brochure
The contraceptives market is likely to provide new vendors with significant growth prospects, particularly in emerging countries. These companies can raise awareness and initiate activities about the usage of contraceptive devices. This is projected to increase contraceptive sales. Moreover, these new providers intend to expand their product offerings by introducing enhanced contraceptive devices. This is anticipated to boost the growth of the market.
Oral (pill) contraceptives, topical contraceptives, and injectable contraceptives are various types of contraceptives. Contraceptive devices, on the other hand, include condoms, intrauterine devices (IUD), vaginal rings, implants, patches, diaphragms, sponges, etc. The barrier method, particularly condoms, is the most common form of artificial contraception.
The global contraceptive market is expected to be driven by an increase in efforts by governments to raise awareness about the negative effects of population growth and unwanted pregnancies.
Stuck in a neck-to-neck competition with other brands? Request a custom report on the Contraceptives Market
Women with unmet contraception needs rarely state that they are unaware of contraception, do not have access to a source of supply, or that it is too expensive. Women in Asia use modern contraception at a lower rate than the global average. In Asia, the majority of unintended pregnancies are caused by the use of traditional contraception or the lack thereof, which results in induced unsafe abortion.
Key barriers to modern contraceptive practice among women in Asia are cultural attitudes, lack of knowledge about methods and reproduction, socio-demographic factors, and healthcare barriers. Lack of knowledge and access could be the most straightforward issues to address in this market. Hence, participants in the market should collaborate with governments to increase awareness about the advantages of contraceptives, which holds the potential to boost product sales.
Key players in the global contraceptives industry are engaged in regulatory approvals, innovations in technologically advanced products, the launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global contraceptive market. A few expansion strategies adopted by players operating in the global contraceptive market are announcing the generic versions of vaginal rings in the U.S. The launch of such vaginal rings can be expected to drive the market for contraceptives.
Healthcare organizations are launching global strategies for accelerating the abolition of cervical cancer. This is expected to augment the global contraception devices market. At the same time, manufacturers are investing in R&D to increase the availability of FDA (Food and Drug Administration)-approved contraceptive options.
|
Attribute |
Detail |
|
Market Size Value in 2020 |
US$ 893.9 Mn |
|
Market Forecast Value in 2028 |
US$ 2,764.7 Mn |
|
Growth Rate (CAGR) |
15.5% |
|
Forecast Period |
2021–2028 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Contraceptives Market – Segmentation
| Product |
|
| Distribution Channel |
|
| Region |
|
The global Contraceptives industry is expected to cross the value of US$ 2.7 Bn by the end of 2028
The global market is estimated to expand at a CAGR of 15.5% from 2021 to 2028
The global market for contraceptives is driven by an increase in efforts by governments to raise awareness about the negative effects of population growth and unwanted pregnancies
North America dominated the global market and the region is expected to account for a major share of the global contraceptives market during the forecast period
Key players in the global market include Smith & Nephew plc, Anika Therapeutics, Inc., DePuy Synthes, Inc., Baxter International, Inc., Stryker Corporation, Medtronic, Inc., Arthrex, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Contraceptives Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Contraceptives Market Analysis and Forecast, 2017–2028
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Global Contraceptives Market - Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Value Chain Analysis
4.9. Market Outlook
5. Global Contraceptives Market Analysis and Forecast, By Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast, by Product, 2017–2028
5.4.1. Contraceptives Drugs
5.4.1.1. Oral Contraceptives
5.4.1.1.1. Combined Contraceptives
5.4.1.1.2. Mini-pills
5.4.1.2. Contraceptive Injectable
5.4.1.3. Topical Contraceptive Patch
5.4.2. Contraceptive Devices
5.4.2.1. Male Contraceptive Devices
5.4.2.2. Female Contraceptive Devices
5.4.2.2.1. Female Condoms
5.4.2.2.2. Contraceptive Diaphragms
5.4.2.2.3. Contraceptive Sponges
5.4.2.2.4. Contraceptive Vaginal Rings
5.4.2.2.5. Intrauterine Devices
5.4.2.2.6. Sub-dermal Contraceptives Implants
5.4.2.2.7. Non-Surgical Permanent Contraception Devices
5.5. Market Attractiveness Analysis, By Product
6. Global Contraceptives Market Analysis and Forecast, By Distribution Channel
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast, by Distribution Channel, 2017–2028
6.4.1. Hospital Pharmacy
6.4.1.1. Public
6.4.1.2. Private
6.4.2. Independent Pharmacy
6.4.3. Online Platform
6.4.4. Clinics
6.4.5. Others
6.5. Market Attractiveness Analysis, By Distribution Channel
7. Global Contraceptives Market Analysis and Forecast, By Region
7.1. Key Findings
7.2. Policies and Regulations
7.3. Market Value Forecast, by Region
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis, By Country/Region
8. North America Contraceptives Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.1.2. Policies and Regulations
8.1.3. Key Trends
8.2. Market Value Forecast, by Product, 2017–2028
8.2.1. Contraceptive Drugs
8.2.1.1. Oral Contraceptives
8.2.1.1.1. Combined Contraceptives
8.2.1.1.2. Mini-pills
8.2.1.2. Contraceptive Injectable
8.2.1.3. Topical Contraceptive Patch
8.2.2. Contraceptive Devices
8.2.2.1. Male Contraceptive Devices
8.2.2.2. Female Contraceptive Devices
8.2.2.2.1. Female Condoms
8.2.2.2.2. Contraceptive Diaphragms
8.2.2.2.3. Contraceptive Sponges
8.2.2.2.4. Contraceptive Vaginal Rings
8.2.2.2.5. Intrauterine Devices
8.2.2.2.6. Sub-dermal Contraceptives Implants
8.2.2.2.7. Non-Surgical Permanent Contraception Devices
8.3. Market Value Forecast, by Distribution Channel, 2017–2028
8.3.1. Hospital Pharmacy
8.3.1.1. Public
8.3.1.2. Private
8.3.2. Independent Pharmacy
8.3.3. Online Platform
8.3.4. Clinics
8.3.5. Others
8.4. Market Value Forecast, by Country, 2017–2028
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product
8.5.2. By Distribution Channel
8.5.3. By Country
9. Europe Contraceptives Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Policies and Regulations
9.1.3. Key Trends
9.2. Market Value Forecast, by Product, 2017–2028
9.2.1. Contraceptive Drugs
9.2.1.1. Oral Contraceptives
9.2.1.1.1. Combined Contraceptives
9.2.1.1.2. Mini-pills
9.2.1.2. Contraceptive Injectable
9.2.1.3. Topical Contraceptive Patch
9.2.2. Contraceptive Devices
9.2.2.1. Male Contraceptive Devices
9.2.2.2. Female Contraceptive Devices
9.2.2.2.1. Female Condoms
9.2.2.2.2. Contraceptive Diaphragms
9.2.2.2.3. Contraceptive Sponges
9.2.2.2.4. Contraceptive Vaginal Rings
9.2.2.2.5. Intrauterine Devices
9.2.2.2.6. Sub-dermal Contraceptives Implants
9.2.2.2.7. Non-Surgical Permanent Contraception Devices
9.3. Market Value Forecast, by Distribution Channel, 2017–2028
9.3.1. Hospital Pharmacy
9.3.1.1. Public
9.3.1.2. Private
9.3.2. Independent Pharmacy
9.3.3. Online Platform
9.3.4. Clinics
9.3.5. Others
9.4. Market Value Forecast, by Country/Sub-region, 2017–2028
9.4.1. Germany
9.4.2. France
9.4.3. U.K.
9.4.4. Spain
9.4.5. Italy
9.4.6. Russia
9.4.7. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Distribution Channel
9.5.3. By Country/Sub-region
10. Asia Pacific Contraceptives Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Policies and Regulations
10.1.3. Key Trends
10.2. Market Value Forecast, by Product, 2017–2028
10.2.1. Contraceptive Drugs
10.2.1.1. Oral Contraceptives
10.2.1.1.1. Combined Contraceptives
10.2.1.1.2. Mini-pills
10.2.1.2. Contraceptive Injectable
10.2.1.3. Topical Contraceptive Patch
10.2.2. Contraceptive Devices
10.2.2.1. Male Contraceptive Devices
10.2.2.2. Female Contraceptive Devices
10.2.2.2.1. Female Condoms
10.2.2.2.2. Contraceptive Diaphragms
10.2.2.2.3. Contraceptive Sponges
10.2.2.2.4. Contraceptive Vaginal Rings
10.2.2.2.5. Intrauterine Devices
10.2.2.2.6. Sub-dermal Contraceptives Implants
10.2.2.2.7. Non-Surgical Permanent Contraception Devices
10.3. Market Value Forecast, by Distribution Channel, 2017–2028
10.3.1. Hospital Pharmacy
10.3.1.1. Public
10.3.1.2. Private
10.3.2. Independent Pharmacy
10.3.3. Online Platforms
10.3.4. Clinics
10.3.5. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2028
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Distribution Channel
10.5.3. By Country/Sub-region
11. Latin America Contraceptives Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Policies and Regulations
11.1.3. Key Trends
11.2. Market Value Forecast, by Product, 2017–2028
11.2.1. Contraceptive Drugs
11.2.1.1. Oral Contraceptives
11.2.1.1.1. Combined Contraceptives
11.2.1.1.2. Mini-pills
11.2.1.2. Contraceptive Injectable
11.2.1.3. Topical Contraceptive Patch
11.2.2. Contraceptive Devices
11.2.2.1. Male Contraceptive Devices
11.2.2.2. Female Contraceptive Devices
11.2.2.2.1. Female Condoms
11.2.2.2.2. Contraceptive Diaphragms
11.2.2.2.3. Contraceptive Sponges
11.2.2.2.4. Contraceptive Vaginal Rings
11.2.2.2.5. Intrauterine Devices
11.2.2.2.6. Sub-dermal Contraceptives Implants
11.2.2.2.7. Non-Surgical Permanent Contraception Devices
11.3. Market Value Forecast, by Distribution Channel, 2017–2028
11.3.1. Hospital Pharmacy
11.3.1.1. Public
11.3.1.2. Private
11.3.2. Independent Pharmacy
11.3.3. Online Platforms
11.3.4. Clinics
11.3.5. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2028
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Distribution Channel
11.5.3. By Country/Sub-region
12. Middle East and Africa Contraceptives Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Policies and Regulations
12.1.3. Key Trends
12.2. Market Value Forecast, by Product, 2017–2028
12.2.1. Contraceptive Drugs
12.2.1.1. Oral Contraceptives
12.2.1.1.1. Combined Contraceptives
12.2.1.1.2. Mini-pills
12.2.1.2. Contraceptive Injectable
12.2.1.3. Topical Contraceptive Patch
12.2.2. Contraceptive Devices
12.2.2.1. Male Contraceptive Devices
12.2.2.2. Female Contraceptive Devices
12.2.2.2.1. Female Condoms
12.2.2.2.2. Contraceptive Diaphragms
12.2.2.2.3. Contraceptive Sponges
12.2.2.2.4. Contraceptive Vaginal Rings
12.2.2.2.5. Intrauterine Devices
12.2.2.2.6. Sub-dermal Contraceptives Implants
12.2.2.2.7. Non-Surgical Permanent Contraception Devices
12.3. Market Value Forecast, by End User, 2017–2028
12.3.1. Hospital Pharmacy
12.3.1.1. Public
12.3.1.2. Private
12.3.2. Independent Pharmacy
12.3.3. Online Platform
12.3.4. Clinics
12.3.5. Others
12.4. Market Value Forecast, by Country /Sub-region, 2017–2028
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of Middle East and Africa
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Distribution Channel
12.5.3. By Country/Sub-region
13. Competition Landscape
13.1. Market Player - Competition Matrix (by tier and size of companies)
13.2. Market Share Analysis, by Company, 2020
13.3. Company Profiles
13.3.1. Merck & Co., Inc.
13.3.1.1. Overview
13.3.1.2. Financials
13.3.1.3. Recent Developments
13.3.1.4. Strategy
13.3.2. Cipla, Inc.
13.3.2.1. Overview
13.3.2.2. Financials
13.3.2.3. Recent Developments
13.3.2.4. Strategy
13.3.3. Allergan plc
13.3.3.1. Overview
13.3.3.2. Financials
13.3.3.3. Recent Developments
13.3.3.4. Strategy
13.3.4. Bayer AG
13.3.4.1. Overview
13.3.4.2. Financials
13.3.4.3. Recent Developments
13.3.4.4. Strategy
13.3.5. HLL Lifecare Limited
13.3.5.1. Overview
13.3.5.2. Financials
13.3.5.3. Recent Developments
13.3.5.4. Strategy
13.3.6. Mankind Pharma
13.3.6.1. Overview
13.3.6.2. Financials
13.3.6.3. Recent Developments
13.3.6.4. Strategy
13.3.7. Pfizer, Inc.
13.3.7.1. Overview
13.3.7.2. Financials
13.3.7.3. Recent Developments
13.3.7.4. Strategy
13.3.8. Teva Pharmaceutical Industries Ltd.
13.3.8.1. Overview
13.3.8.2. Financials
13.3.8.3. Recent Developments
13.3.8.4. Strategy
13.3.9. Mithra Pharmaceuticals
13.3.9.1. Overview
13.3.9.2. Financials
13.3.9.3. Recent Developments
13.3.9.4. Strategy
13.3.10. Janssen Pharmaceutical Company
13.3.10.1. Overview
13.3.10.2. Financials
13.3.10.3. Recent Developments
13.3.10.4. Strategy
13.3.11. Reckitt Benckiser Group plc
13.3.11.1. Overview
13.3.11.2. Financials
13.3.11.3. Recent Developments
13.3.11.4. Strategy
List of Tables
Table 01: Global Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017–2028
Table 02: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017–2028
Table 03: Global Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017–2028
Table 04: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017–2028
Table 05: Global Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017–2028
Table 06: Global Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2028
Table 07: Global Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017–2028
Table 08: Global Contraceptives Market Size (US$ Mn) Forecast, by Region, 2017–2028
Table 09: North America Contraceptives Market Size (US$ Mn) Forecast, by Country, 2017–2028
Table 10: North America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017–2028
Table 11: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017–2028
Table 12: North America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017–2028
Table 13: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017–2028
Table 14: North America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017–2028
Table 15: North America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2028
Table 16: North America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017–2028
Table 17: Europe Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 18: Europe Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017–2028
Table 19: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017–2028
Table 20: Europe Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017–2028
Table 21: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017–2028
Table 22: Europe Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017–2028
Table 23: Europe Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2028
Table 24: Europe Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017–2028
Table 25: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 26: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017–2028
Table 27: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017–2028
Table 28: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017–2028
Table 29: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017–2028
Table 30: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017–2028
Table 31: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2028
Table 32: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017–2028
Table 33: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 34: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017–2028
Table 35: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017–2028
Table 36: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017–2028
Table 37: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017–2028
Table 38: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017–2028
Table 39: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2028
Table 40: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017–2028
Table 41: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 42: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017–2028
Table 43: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017–2028
Table 44: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017–2028
Table 45: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017–2028
Table 46: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017–2028
Table 47: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2028
Table 48: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017–2028
List of Figures
Figure 01: Global Contraceptives, Market Size (US$ Mn) Forecast, 2017–2028
Figure 02: Global Contraceptives Market Value Share, by Product (2020)
Figure 03: Global Contraceptives Market Value Share, by Distribution Channel, 2020
Figure 04: Global Contraceptives Market Value Share, by Region, 2020
Figure 05: Global Contraceptives Market Value Share, by Product Type, 2017 and 2028
Figure 06: Global Contraceptives Market Attractiveness Analysis, by Product Type, 2017–2028
Figure 07: Global Contraceptives Market Value Share, by Contraceptive Drugs, 2017 and 2028
Figure 08: Global Contraceptives Market Attractiveness Analysis, by Contraceptive Drugs, 2017–2028
Figure 09: Global Contraceptives Market Value Share, by Oral Contraceptives, 2017 and 2028
Figure 10: Global Contraceptives Market Attractiveness Analysis, by Oral Contraceptives, 2017–2028
Figure 11: Global Contraceptives Market Value Share, by Contraceptive Devices, 2017 and 2028
Figure 12: Global Contraceptives Market Attractiveness Analysis, by Contraceptive Devices, 2017–2028
Figure 13: Global Contraceptives Market Value Share, by Female Contraceptive Devices, 2017 and 2028
Figure 14: Global Contraceptives Market Attractiveness Analysis, by Female Contraceptive Devices, 2017–2028
Figure 15: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Drugs, 2017–2028
Figure 16: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Devices, 2017–2028
Figure 17: Global Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
Figure 18: Global Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017–2028
Figure 19: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacy, 2017–2028
Figure 20: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacy, 2017–2028
Figure 21: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Platform, 2017–2028
Figure 22: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinic, 2017–2028
Figure 23: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2028
Figure 24: Global Contraceptives Market Value Share, by Region, 2017 and 2028
Figure 25: Global Contraceptives Market Attractiveness Analysis, by Region, 2017–2028
Figure 26: North America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028
Figure 27: North America Contraceptives Market Attractiveness Analysis, by Country 2017–2028
Figure 28: North America Contraceptives Market Value Share, by Country, 2017 and 2028
Figure 29: North America Contraceptives Market Value Share, by Product Type, 2017 and 2028
Figure 30: North America Contraceptives Market Attractiveness Analysis, by Product Type, 2017–2028
Figure 31: North America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
Figure 32: North America Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017–2028
Figure 33: Europe Contraceptives Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 34: Europe Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017–2028
Figure 35: Europe Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028
Figure 36: Europe Contraceptives Market Value Share, by Product, 2017 and 2028
Figure 37: Europe Contraceptives Market Attractiveness Analysis, by Product, 2017–2028
Figure 38: Europe Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
Figure 39: Europe Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017–2028
Figure 40: Asia Pacific Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028
Figure 41: Asia Pacific Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017–2028
Figure 42: Asia Pacific Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028
Figure 43: Asia Pacific Contraceptives Market Value Share, by Product Type, 2017 and 2028
Figure 44: Asia Pacific Contraceptives Market Attractiveness Analysis, by Product Type, 2017–2028
Figure 45: Asia Pacific Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
Figure 46: Asia Pacific Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017–2028
Figure 47: Latin America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028
Figure 48: Latin America Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017–2028
Figure 49: Latin America Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028
Figure 50: Latin America Contraceptives Market Value Share, by Product Type, 2017 and 2028
Figure 51: Latin America Contraceptives Market Attractiveness Analysis, by Product Type, 2017–2028
Figure 52: Latin America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
Figure 53: Latin America Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017–2028
Figure 54: Middle East & Africa Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028
Figure 55: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017–2028
Figure 56: Middle East & Africa Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028
Figure 57: Middle East & Africa Contraceptives Market Value Share, by Product Type, 2017 and 2028
Figure 58: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Product Type, 2017–2028
Figure 59: Middle East & Africa Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
Figure 60: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017–2028
Figure 61: Global Contraceptives Drugs Market Share, by Company, 2020
Figure 62: Global Contraceptives Devices Market Share, by Company, 2020
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Contraceptives Market
*86 figures and 60 tables includes